Treatment of malignant gastric outlet obstruction with stents: An evaluation of the reported variables for clinical outcome
<p>Abstract</p> <p>Background</p> <p>Malignant gastric outlet obstruction (GOO) is commonly seen in patients with advanced gastric-, pancreatic-, duodenal, hepatobiliary or metastatic malignancies. Ten to 25% of patients with pancreatic cancer will develop duodenal obst...
Main Authors: | Medhus Asle W, Larssen Lene, Hauge Truls |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-06-01
|
Series: | BMC Gastroenterology |
Online Access: | http://www.biomedcentral.com/1471-230X/9/45 |
Similar Items
-
Antroduodenal Stenting for Malignant Gastric Outlet Obstruction: Technique and Outcome
by: Uday C. Ghoshal, et al.
Published: (2019-01-01) -
The location of obstruction predicts stent occlusion in malignant gastric outlet obstruction
by: Douglas Grunwald, et al.
Published: (2016-11-01) -
Impact of Carcinomatosis on Clinical Outcomes after Self-Expandable Metallic Stent Placement for Malignant Gastric Outlet Obstruction.
by: Ji Eun Lee, et al.
Published: (2015-01-01) -
Predictors of self-expanding metallic stent dysfunction in malignant gastric outlet obstruction
by: L.S. Suder-Castro, et al.
Published: (2020-07-01) -
Pyloric stent insertion in malignant gastric outlet obstruction: moving beyond palliation
by: Saad Muhammad Saeed, et al.
Published: (2021-09-01)